• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化-MED1 增强的 UBE2C 基因座环化驱动去势抵抗性前列腺癌生长。

Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.

机构信息

Department of Molecular and Cellular Biochemistry and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH, USA.

出版信息

EMBO J. 2011 May 10;30(12):2405-19. doi: 10.1038/emboj.2011.154.

DOI:10.1038/emboj.2011.154
PMID:21556051
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3116285/
Abstract

The UBE2C oncogene is overexpressed in many types of solid tumours including the lethal castration-resistant prostate cancer (CRPC). The underlying mechanisms causing UBE2C gene overexpression in CRPC are not fully understood. Here, we show that CRPC-specific enhancers drive UBE2C overexpression in both AR-negative and -positive CRPC cells. We further show that co-activator MED1 recruitment to the UBE2C enhancers is required for long-range UBE2C enhancer/promoter interactions. Importantly, we find that the molecular mechanism underlying MED1-mediated chromatin looping involves PI3K/AKT phosphorylated MED1-mediated recruitment of FoxA1, RNA polymerase II and TATA binding protein and their subsequent interactions at the UBE2C locus. MED1 phosphorylation leads to UBE2C locus looping, UBE2C gene expression and cell growth. Our results not only define a causal role of a post-translational modification (phosphorylation) of a co-activator (MED1) in forming or sustaining an active chromatin structure, but also suggest that development of specific therapies for CRPC should take account of targeting phosphorylated MED1.

摘要

UBE2C 癌基因在许多实体肿瘤中过表达,包括致命的去势抵抗性前列腺癌(CRPC)。导致 CRPC 中 UBE2C 基因过表达的潜在机制尚未完全阐明。在这里,我们表明 CRPC 特异性增强子驱动 AR 阴性和阳性 CRPC 细胞中 UBE2C 的过表达。我们进一步表明,共激活因子 MED1 募集到 UBE2C 增强子对于长距离 UBE2C 增强子/启动子相互作用是必需的。重要的是,我们发现 MED1 介导的染色质环looping 的分子机制涉及 PI3K/AKT 磷酸化的 MED1 介导的 FoxA1、RNA 聚合酶 II 和 TATA 结合蛋白的募集及其随后在 UBE2C 基因座上的相互作用。MED1 磷酸化导致 UBE2C 基因座环looping、UBE2C 基因表达和细胞生长。我们的研究结果不仅定义了一种翻译后修饰(磷酸化)的共激活因子(MED1)在形成或维持活性染色质结构中的因果作用,而且还表明,针对 CRPC 的特定治疗方法的开发应考虑靶向磷酸化的 MED1。

相似文献

1
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.磷酸化-MED1 增强的 UBE2C 基因座环化驱动去势抵抗性前列腺癌生长。
EMBO J. 2011 May 10;30(12):2405-19. doi: 10.1038/emboj.2011.154.
2
MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.MED1在缺乏配体的情况下介导雄激素受体剪接变体诱导的基因表达。
Oncotarget. 2015 Jan 1;6(1):288-304. doi: 10.18632/oncotarget.2672.
3
CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.CCI-779 通过抑制 UBE2C 转录和 mRNA 稳定性来抑制去势抵抗性前列腺癌的细胞周期 G2-M 进展和侵袭。
Cancer Res. 2011 Jul 15;71(14):4866-76. doi: 10.1158/0008-5472.CAN-10-4576. Epub 2011 May 18.
4
Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.激素敏感性前列腺癌和去势抵抗性前列腺癌中雄激素受体变异体7和泛素结合酶2C的转录水平
Prostate. 2017 Jan;77(1):60-71. doi: 10.1002/pros.23248. Epub 2016 Aug 22.
5
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.CDK7 抑制通过 MED1 失活抑制去势抵抗性前列腺癌。
Cancer Discov. 2019 Nov;9(11):1538-1555. doi: 10.1158/2159-8290.CD-19-0189. Epub 2019 Aug 29.
6
ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.ERK 和 AKT 信号通路驱动前列腺癌中 MED1 的过表达,与增殖和致瘤性升高有关。
Mol Cancer Res. 2013 Jul;11(7):736-47. doi: 10.1158/1541-7786.MCR-12-0618. Epub 2013 Mar 28.
7
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.配体依赖性全长雄激素受体及其剪接变体在去势抵抗性前列腺癌中介导的独特转录程序。
Cancer Res. 2012 Jul 15;72(14):3457-62. doi: 10.1158/0008-5472.CAN-11-3892. Epub 2012 Jun 18.
8
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.在雄激素剥夺条件下,去势抵抗性前列腺癌中持续的雄激素受体介导的转录。
Nucleic Acids Res. 2012 Nov;40(21):10765-79. doi: 10.1093/nar/gks888. Epub 2012 Sep 27.
9
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.增强子 RNA 参与雄激素受体驱动的环化,从而选择性地增强基因激活。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.
10
Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1.雄激素受体与中介复合物的相互作用在去势抵抗性前列腺癌中通过 CDK7 对 MED1 的磷酸化作用得到增强。
Cancer Discov. 2019 Nov;9(11):1490-1492. doi: 10.1158/2159-8290.CD-19-1028.

引用本文的文献

1
The Mediator Complex: A Regulatory Hub for Transcriptional Activity of Nuclear Receptors.中介体复合物:核受体转录活性的调控枢纽
Cells. 2025 Aug 28;14(17):1335. doi: 10.3390/cells14171335.
2
A phosphorylation switch in the Mediator MED15 controls cellular senescence and cognitive decline.中介体MED15中的磷酸化开关控制细胞衰老和认知衰退。
Cell Discov. 2025 Aug 19;11(1):69. doi: 10.1038/s41421-025-00820-1.
3
Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.长链非编码RNA在前列腺癌发生发展及诊断治疗中的机制与进展
Int Urol Nephrol. 2025 Apr 23. doi: 10.1007/s11255-025-04497-z.
4
miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer.miR-205通过靶向雌激素受体共激活因子MED1调控人乳腺癌中他莫昔芬耐药性。
Cancers (Basel). 2024 Nov 28;16(23):3992. doi: 10.3390/cancers16233992.
5
Ubiquitination-Binding Enzyme 2C is Associated with Cancer Development and Prognosis and is a Potential Therapeutic Target.泛素化结合酶2C与癌症发生发展及预后相关,是一个潜在的治疗靶点。
Onco Targets Ther. 2024 Dec 7;17:1159-1171. doi: 10.2147/OTT.S485053. eCollection 2024.
6
Targeting CDK7 enhances the antitumor efficacy of enzalutamide in androgen receptor-positive triple-negative breast cancer by inhibiting c-MYC-mediated tumorigenesis.靶向CDK7通过抑制c-MYC介导的肿瘤发生增强恩杂鲁胺在雄激素受体阳性三阴性乳腺癌中的抗肿瘤疗效。
Mol Cancer Ther. 2024 Nov 26. doi: 10.1158/1535-7163.MCT-23-0386.
7
Machine learning-based cell death marker for predicting prognosis and identifying tumor immune microenvironment in prostate cancer.基于机器学习的细胞死亡标志物用于预测前列腺癌的预后并识别肿瘤免疫微环境
Heliyon. 2024 Sep 6;10(18):e37554. doi: 10.1016/j.heliyon.2024.e37554. eCollection 2024 Sep 30.
8
[Biological role of SPAG5 in the malignant proliferation of gastric cancer cells].[精子相关抗原5(SPAG5)在胃癌细胞恶性增殖中的生物学作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Aug 20;44(8):1497-1507. doi: 10.12122/j.issn.1673-4254.2024.08.08.
9
[Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].基于高通量RNA测序的肾母细胞瘤关键基因鉴定及其对预后和免疫反应的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Apr 20;44(4):727-738. doi: 10.12122/j.issn.1673-4254.2024.04.15.
10
Regulation of Med1 protein by overexpression of BAP1 in breast cancer cells.乳腺癌细胞中BAP1过表达对Med1蛋白的调控
Mol Cell Oncol. 2024 May 2;11(1):2347827. doi: 10.1080/23723556.2024.2347827. eCollection 2024.

本文引用的文献

1
Functional and mechanistic diversity of distal transcription enhancers.远端转录增强子的功能和机制多样性。
Cell. 2011 Feb 4;144(3):327-39. doi: 10.1016/j.cell.2011.01.024.
2
Mediator and cohesin connect gene expression and chromatin architecture.中介体和黏合蛋白连接基因表达和染色质结构。
Nature. 2010 Sep 23;467(7314):430-5. doi: 10.1038/nature09380. Epub 2010 Aug 18.
3
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.雄激素受体、多梳、TMPRSS2-ERG 基因融合在前列腺癌进展中的整合网络。
Cancer Cell. 2010 May 18;17(5):443-54. doi: 10.1016/j.ccr.2010.03.018.
4
Widespread transcription at neuronal activity-regulated enhancers.神经元活动调节增强子的广泛转录。
Nature. 2010 May 13;465(7295):182-7. doi: 10.1038/nature09033. Epub 2010 Apr 14.
5
The human Mediator complex: a versatile, genome-wide regulator of transcription.人类中介体复合物:一种通用的、全基因组转录调控因子。
Trends Biochem Sci. 2010 Jun;35(6):315-22. doi: 10.1016/j.tibs.2010.02.004. Epub 2010 Mar 17.
6
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.同谋:前列腺癌中 AR 活性和雄激素合成的去调控。
Trends Endocrinol Metab. 2010 May;21(5):315-24. doi: 10.1016/j.tem.2010.01.002. Epub 2010 Feb 6.
7
Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.E2 泛素连接酶 UbcH10 的过表达导致染色体错误分离和肿瘤形成。
J Cell Biol. 2010 Jan 11;188(1):83-100. doi: 10.1083/jcb.200906147.
8
Transcription factors mediate long-range enhancer-promoter interactions.转录因子介导长程增强子-启动子相互作用。
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20222-7. doi: 10.1073/pnas.0902454106. Epub 2009 Nov 18.
9
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources.BioGPS:一个可扩展和可定制的门户,用于查询和组织基因注释资源。
Genome Biol. 2009;10(11):R130. doi: 10.1186/gb-2009-10-11-r130. Epub 2009 Nov 17.
10
An oestrogen-receptor-alpha-bound human chromatin interactome.一个与雌激素受体α结合的人类染色质相互作用组。
Nature. 2009 Nov 5;462(7269):58-64. doi: 10.1038/nature08497.